Health Care Friday

  • WaPo: What cable won’t tell you.

    Even as the national business lobby ramps up its opposition to health-care reform, there are signs that employers around the country are divided on the issue, reducing the force of an opposition push.

    Reuters: Why it matters:

    President Barack Obama said on Wednesday he realized Americans were skeptical about his healthcare overhaul, but that the country’s economic recovery depended on implementing the $1 trillion plan.

    Reprise:

    SUMMARY: CNN, Fox News Channel, and MSNBC aired at least 15 segments to discussing the Congressional Budget Office’s preliminary analysis of an incomplete version of the Senate health committee’s draft health reform bill, but they have aired only one segment to the CBO’s analysis of the updated bill.

  • WaPo:

    The Food and Drug Administration said Wednesday that an analysis of leading brands of electronic cigarettes, a new type of “smokeless” nicotine product, detected carcinogens and a chemical used in antifreeze that is toxic to humans.

    But, hey, it’s modern and technological!

    USA Today:

    The Food and Drug Administration, recently granted the authority to regulate tobacco as a drug, is taking aim at electronic cigarettes — battery-powered cigarette look-alikes that deliver nicotine and produce a puff of odorless vapor.

    NY Times:

    Electronic cigarettes contain traces of toxic substances and carcinogens, according to a preliminary analysis of the products by the Food and Drug Administration.

    Stick with pot. It’s safer.

  • HealthDay:

    Vaccines are not only for children, but many young adults in the United States are unaware of the need to keep up with their shots, a new survey shows.

    For example, while 84 percent of Americans over 50 know that tetanus causes lockjaw and that they need to get a new tetanus shot every 10 years, only 49 percent of adults aged 18 to 26 know this, according to a survey commissioned by the National Foundation for Infectious Diseases (NFID).

    But, y’know, death and disease is a scam by Big Pharma.

  • Via press release:

    At today’s conclusion of the 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2009) the International AIDS Society welcomed evidence illustrating how investments in HIV have contributed to reductions in infant mortality and TB incidence, improved access to health services for women, and expanded health systems capacity.

    Ten years ago there was less than US$1 billion available for HIV programmes globally. By 2009, there is US$14 billion available. These investments have generated substantial returns in addressing the HIV epidemic — in particular, four million people who would otherwise be dead are now on HIV treatment and alive. Data suggest that the number of new infections has peaked, due in part to successful prevention efforts. In addition, new evidence presented at this conference suggests that treatment on a large scale can not only save the lives of individual patients receiving care, but also curb the epidemic by reducing viral loads and thereby infectiousness.

    More here.

  • Bloomberg: Is this what we’ll see in the fall?

    Intensive care units in some New Zealand hospitals are full and a spike in flu cases has prompted doctors to postpone non-essential surgery to ease pressure on medical services, the country’s health ministry said.

    Seventy-four people are hospitalized with the H1N1 pandemic virus, also known as swine flu, with 26 in intensive care, in the nation of 4.2 million people, the ministry said in a statement today.

    Hey, but it’s just like seasonal flu… except for the age group it hits, the severity of illness, the tendency to hit deeper in the lung, and the fact that it didn’t go away this summer.

    Excellent Swine Flu Basics diary here.

  • Press release from Trust for America’s Health:

    Infectious Diseases Physicians and Public Health Experts Call FDA’s New Approach for Antimicrobial Use in Animals a Major Win for Patient Care and Food Safety


Leave a Reply